The parathyroid surgeon synthesizes these inputs to determine the extent of resection—focused parathyroidectomy for localized adenomas versus subtotal resection for multiglandular disease (e.g., MEN1 carriers)—aided by intraoperative PTH monitoring to confirm cure (125). The gene discussed is MEN1; the disease is adenoma.